|

PHN-012 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Pheon Therapeutics1

Indications

  • Lung Cancer (NSCLC)1
  • Advanced Cancer1
  • Pancreatic Cancer1
  • Colon Cancer1
  • Advanced Solid Tumors1

Washington D.C., District of Columbia1 trial

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.